Media

Learn more about us in our featured news stories and insights into the work that we do.

News Press Releases Locus Insights

November 10, 2022

2022 Fast 50 Awards: No. 11 – Locus Biosciences

Learn More
September 13, 2022

Locus Biosciences Announces First Patient Treated in the ELIMINATE Registrational Phase 2/3 Trial of LBP-EC01 for Urinary Tract Infections

Learn More
May 20, 2022

J&J backed Locus closes $35M financing to push CRISPR-based antibacterial drug into phase 2/3

Learn More
May 18, 2022

RTP’s Locus Biosciences closes $35M Series B, investors include J&J and Tencent

Learn More
May 18, 2022

Locus Biosciences Announces $35 Million Financing

Learn More
April 6, 2022

Bacteriophages

Learn More
April 6, 2022

INDUSTRY MATTERS: LOCUS BIOSCIENCES ENLISTS CRISPR-ENHANCED BACTERIOPHAGES TO COMBAT RESISTANT BACTERIA.

Learn More
April 4, 2022

Bacteriophage (Phage) Therapy

Learn More
April 3, 2022

Locus Biomanufacturing Solutions Facility

Learn More
April 2, 2022

Urinary Tract Infections

Learn More

Careers

We are on a mission to revolutionize the treatment of disease. We need intelligent, open, hard-working people who thrive in a fast-paced environment to join us on our quest.